Sulindac, a nonsteroidal anti-inflammatory drug, selectively inhibits interferon-γ-induced expression of the chemokine CXCL9 gene in mouse macrophages

Biochemical and Biophysical Research Communications

Volumn 350, Issue 2, 2006, Pages 339-344

  Sakaeda, Yoshiichi ^a   Hiroi, Miki ^a   Shimojima, Takahiro ^a   Iguchi, Mayumi ^a   Kanegae, Haruhide ^a   Ohmori, Yoshihiro ^a  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

Author keywords

Chemokine; CXCL9; Gene expression; Interferon ; Macrophages; NF B; NSAID; STAT1; Sulindac

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; LUCIFERASE; MESSENGER RNA; SALICYLATE SODIUM; STAT1 PROTEIN; SULINDAC;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; GENE ACTIVITY; GENE EXPRESSION; IMMUNOCOMPETENT CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; CHEMOKINE CXCL9; CHEMOKINES, CXC; DOWN-REGULATION; INTERFERON TYPE II; INTERFERON-GAMMA; MACROPHAGES; MICE; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; SULINDAC; TRANS-ACTIVATION (GENETICS); TRANSCRIPTIONAL ACTIVATION;

EID: 33749352227     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.09.058     Document Type: Article

References (27)

1. Ohmori Y., and Hamilton T.A. Regulation of macrophage gene expression by T-cell-derived lymphokines. Pharmacol. Ther. 63 (1994) 235-264
2. Boehm U., Klamp T., Groot M., and Howard J.C. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15 (1997) 749-795
3. Loetscher M., Gerber B., Loetscher P., Jones S.A., Piali L., Clark-Lewis I., Baggiolini M., and Moser B. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184 (1996) 963-969
4. Farber J.M. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leuk. Biol. 61 (1997) 246-257
5. Rotondi M., Lazzeri E., Romagnani P., and Serio M. Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field. J. Endocrinol. Invest. 26 (2003) 177-180
6. Tannenbaum C.S., Tubbs R., Armstrong D., Finke J.H., Bukowski R.M., and Hamilton T.A. The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J. Immunol. 161 (1998) 927-932
7. Thun M.J., Henley S.J., and Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J. Natl. Cancer Inst. 94 (2002) 252-266
8. Shiff S.J., Qiao L., Tsai L.L., and Rigas B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. Clin. Invest. 96 (1995) 491-503
9. Yamamoto Y., Yin M.J., Lin K.M., and Gaynor R.B. Sulindac inhibits activation of the NF-kappaB pathway. J. Biol. Chem. 274 (1999) 27307-27314
10. Rice P.L., Goldberg R.J., Ray E.C., Driggers L.J., and Ahnen D.J. Inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and induction of apoptosis by sulindac metabolites. Cancer Res. 61 (2001) 1541-1547
11. Chirgwin J.M., Przybyla A.E., MacDonald R.J., and Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18 (1979) 5294-5299
12. Ohmori Y., Schreiber R.D., and Hamilton T.A. Synergy between interferon-γ and tumor necrosis factor-α in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor κB. J. Biol. Chem. 272 (1997) 14899-14907
13. Wright T.M., and Farber J.M. 5' regulatory region of a novel cytokine gene mediates selective activation by interferon gamma. J. Exp. Med. 173 (1991) 417-422
14. Ohmori Y., and Hamilton T.A. STAT6 is required for the anti-inflammatory activity of interleukin-4 in mouse peritoneal macrophages. J. Biol. Chem. 273 (1998) 29202-29209
15. Ohmori Y., and Hamilton T.A. Cooperative interaction between interferon (IFN) stimulus response element and κB sequence motifs controls IFN γ- and lipopolysaccharide-stimulated transcription from the murine IP-10 promoter. J. Biol. Chem. 268 (1993) 6677-6688
16. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11 (1983) 1475-1489
17. Hiroi M., and Ohmori Y. The transcriptional coactivator CREB-binding protein cooperates with STAT1 and NF-kappa B for synergistic transcriptional activation of the CXC ligand 9/monokine induced by interferon-gamma gene. J. Biol. Chem. 278 (2003) 651-660
18. Sims S.H., Cha Y., Romine M.F., Gao P.Q., Gottlieb K., and Deisseroth A.B. A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol. Cell. Biol. 13 (1993) 690-702
19. Ohmori Y., and Hamilton T.A. The interferon-stimulated response element and a κB site mediate synergistic induction of murine IP-10 gene transcription by IFN-γ and TNF-α. J. Immunol. 154 (1995) 5235-5244
20. Gautam S.C., Pindolia K.R., Noth C.J., Janakiraman N., Xu Y.X., and Chapman R.A. Chemokine gene expression in bone marrow stromal cells: downregulation with sodium salicylate. Blood 86 (1995) 2541-2550
21. Cieslik K., Zhu Y., and Wu K.K. Salicylate suppresses macrophage nitric-oxide synthase-2 and cyclo-oxygenase-2 expression by inhibiting CCAAT/enhancer-binding protein-beta binding via a common signaling pathway. J. Biol. Chem. 277 (2002) 49304-49310
22. Wong P., Severns C.W., Guyer N.B., and Wright T.M. A unique palindromic element mediates gamma interferon induction of mig gene expression. Mol. Cell. Biol. 14 (1994) 914-922
23. Vinkemeier U., Cohen S.L., Moarefi I., Chait B.T., Kuriyan J., and Darnell Jr. J.E. DNA binding of in vitro activated Stat1 alpha, Stat1 beta and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites. EMBO J. 15 (1996) 5616-5626
24. Hiroi M., and Ohmori Y. Constitutive nuclear factor κB activity is required to elicit interferon-gamma-induced expression of chemokine CXC ligand 9 (CXCL9) and CXCL10 in human tumour cell lines. Biochem. J. 376 (2003) 393-402
25. Matsumoto M., Tanaka N., Harada H., Kimura T., Yokochi T., Kitagawa M., Schindler C., and Taniguchi T. Activation of the transcription factor ISGF3 by interferon-gamma. Biol. Chem. 380 (1999) 699-703
26. Zeng X., Moore T.A., Newstead M.W., Deng J.C., Kunkel S.L., Luster A.D., and Standiford T.J. Interferon-inducible protein 10, but not monokine induced by gamma interferon, promotes protective type 1 immunity in murine Klebsiella pneumoniae pneumonia. Infect. Immun. 73 (2005) 8226-8236
27. Niv Y., and Fraser G.M. Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy. Gastroenterology 107 (1994) 854-857